These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22183708)

  • 21. Circulating anti-PLA2R autoantibodies to monitor immunological activity in membranous nephropathy.
    Cravedi P; Ruggenenti P; Remuzzi G
    J Am Soc Nephrol; 2011 Aug; 22(8):1400-2. PubMed ID: 21784892
    [No Abstract]   [Full Text] [Related]  

  • 22. Segmental membranous nephropathy with severe IgG3 deposition.
    Kondo A; Hashimura Y; Uchiyama T; Yoshikawa N; Minami H
    Pediatr Int; 2018 Jun; 60(6):597-598. PubMed ID: 29744961
    [No Abstract]   [Full Text] [Related]  

  • 23. A rare case of PLA2R- and THSD7A-positive idiopathic membranous nephropathy.
    Wanderley DC; Jones BD; Barbosa FAM; Araujo SA
    J Bras Nefrol; 2019 Oct; 42(2):254-258. PubMed ID: 31663595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases.
    Radice A; Pieruzzi F; Trezzi B; Ghiggeri G; Napodano P; D'Amico M; Stellato T; Brugnano R; Ravera F; Rolla D; Pesce G; Giovenzana ME; Londrino F; Cantaluppi V; Pregnolato F; Volpi A; Rombolà G; Moroni G; Ortisi G; Sinico RA
    J Nephrol; 2018 Apr; 31(2):271-278. PubMed ID: 29081027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunological remission in PLA2R-antibody-associated membranous nephropathy: cyclophosphamide versus rituximab.
    van de Logt AE; Dahan K; Rousseau A; van der Molen R; Debiec H; Ronco P; Wetzels J
    Kidney Int; 2018 Apr; 93(4):1016-1017. PubMed ID: 29571438
    [No Abstract]   [Full Text] [Related]  

  • 26. Membranous Nephropathy Associated With Immunological Disorder-Related Liver Disease: A Retrospective Study of 10 Cases.
    Dauvergne M; Moktefi A; Rabant M; Vigneau C; Kofman T; Burtey S; Corpechot C; Stehlé T; Desvaux D; Rioux-Leclercq N; Rouvier P; Knebelmann B; Boffa JJ; Frouget T; Daugas E; Jablonski M; Dahan K; Brocheriou I; Remy P; Grimbert P; Lang P; Chazouilleres O; Sahali D; Audard V
    Medicine (Baltimore); 2015 Jul; 94(30):e1243. PubMed ID: 26222864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PLA2R related primary membranous nephropathy in a hepatitis C positive patient.
    Ramachandran R; Yadav AK; Kumar V; Varma A; Taneja S; Nada R; Gupta KL; Jha V
    Nephrology (Carlton); 2018 Mar; 23(3):288. PubMed ID: 29460999
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical features, course and prognosis of idiopathic membranous nephropathy depending on the presence of antibodies against M-type phospholipase A2 receptor.
    Jatem Escalante E; Segarra Medrano A; Carnicer Cáceres C; Martín-Gómez MA; Salcedo Allende MT; Ostos Roldan H; Agraz Pamplona I
    Nefrologia; 2015; 35(5):479-86. PubMed ID: 26306972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Membranous glomerulonephritis: histological and serological features to differentiate cancer-related and non-related forms.
    Murtas C; Ghiggeri GM
    J Nephrol; 2016 Aug; 29(4):469-78. PubMed ID: 26810113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-PLA2R-associated membranous nephropathy: a review with emphasis on diagnostic testing methods.
    VanBeek C; Haas M
    Clin Nephrol; 2015 Jul; 84(1):1-9. PubMed ID: 25997506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of autoantibodies in primary membranous nephropathy and their clinical significance.
    Stahl RA; Reinhard L; Hoxha E
    Expert Rev Clin Immunol; 2019 Feb; 15(2):165-175. PubMed ID: 30433832
    [No Abstract]   [Full Text] [Related]  

  • 32. Antiribosomal-P protein antibodies are associated with proliferative glomerulonephritis more strongly than with membranous glomerulonephritis in Japanese patients with systemic lupus erythematosus.
    Yoshio T; Okamoto H; Onishi S; Minota S
    Mod Rheumatol; 2012 Jun; 22(3):488-90. PubMed ID: 22042098
    [No Abstract]   [Full Text] [Related]  

  • 33. Concurrent mucous membrane pemphigoid and membranous glomerulonephritis in a patient with autoantibodies targeting the 1080 region of collagen XVII.
    Stump M; Messingham KN; Fairley JA
    Br J Dermatol; 2019 Oct; 181(4):835-836. PubMed ID: 30916378
    [No Abstract]   [Full Text] [Related]  

  • 34. Novel ELISA for thrombospondin type 1 domain-containing 7A autoantibodies in membranous nephropathy.
    Zaghrini C; Seitz-Polski B; Justino J; Dolla G; Payré C; Jourde-Chiche N; Van de Logt AE; Booth C; Rigby E; Lonnbro-Widgren J; Nystrom J; Mariat C; Cui Z; Wetzels JFM; Ghiggeri G; Beck LH; Ronco P; Debiec H; Lambeau G
    Kidney Int; 2019 Mar; 95(3):666-679. PubMed ID: 30784662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy.
    Sethi S; Debiec H; Madden B; Charlesworth MC; Morelle J; Gross L; Ravindran A; Buob D; Jadoul M; Fervenza FC; Ronco P
    Kidney Int; 2020 Jan; 97(1):163-174. PubMed ID: 31901340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.
    Beck LH; Bonegio RG; Lambeau G; Beck DM; Powell DW; Cummins TD; Klein JB; Salant DJ
    N Engl J Med; 2009 Jul; 361(1):11-21. PubMed ID: 19571279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unmet challenges in membranous nephropathy.
    Salant DJ
    Curr Opin Nephrol Hypertens; 2019 Jan; 28(1):70-76. PubMed ID: 30451735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Membranous nephropathy and anti-neutrophil cytoplasmic antibody-associated glomerulonephritis: a report of 2 cases.
    Dwyer KM; Agar JW; Hill PA; Murphy BF
    Clin Nephrol; 2001 Nov; 56(5):394-7. PubMed ID: 11758012
    [No Abstract]   [Full Text] [Related]  

  • 39. Cross-reactivity of anti-PLA2R1 autoantibodies to rabbit and mouse PLA2R1 antigens and development of two novel ELISAs with different diagnostic performances in idiopathic membranous nephropathy.
    Seitz-Polski B; Dolla G; Payré C; Tomas NM; Lochouarn M; Jeammet L; Mariat C; Krummel T; Burtey S; Courivaud C; Schlumberger W; Zorzi K; Benzaken S; Bernard G; Esnault VL; Lambeau G
    Biochimie; 2015 Nov; 118():104-15. PubMed ID: 26296473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibodies to m-type phospholipase A2 receptor in children with idiopathic membranous nephropathy.
    Kumar V; Ramachandran R; Kumar A; Nada R; Suri D; Gupta A; Kohli HS; Gupta KL; Jha V
    Nephrology (Carlton); 2015 Aug; 20(8):572-5. PubMed ID: 26194981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.